Why the study?
Is lower LV mass during antihypertensive treatment associated with lower rates of clinical end points in patients with essential hypertension and baseline electrocardiographic LV hypertrophy?
Is lower LV mass during antihypertensive treatment associated with lower rates of clinical end points in patients with essential hypertension and baseline electrocardiographic LV hypertrophy?
Reduction in left ventricular mass during antihypertensive therapy provides prognostic benefits independent of blood pressure reduction.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Richard B. Devereux (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: